Fatty acid amide hydrolase competitively degrades bioactive amides and esters through a nonconventional catalytic mechanism

被引:124
|
作者
Patricelli, MP
Cravatt, BF
机构
[1] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1021/bi991876p
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The greater reactivity of esters relative to amides has typically been reflected in their faster rates of both solvolysis and enzymatic hydrolysis, In contrast to this general principle, the serine hydrolytic enzyme fatty acid amide hydrolase (FAAH) was found to degrade amides and esters with equivalent catalytic efficiencies. Mutation of a single lysine residue (K142) to alanine (K142A) abolished this property, generating a catalytically compromised enzyme that hydrolyzed esters more than 500-fold faster than amides. Conversion of this same lysine residue to glutamic acid (K132E) produced an enzyme that also displayed severely diminished catalytic activity, but one that now maintained FAAH's ability to react with amides and esters at competitive rates. The significant catalytic defects exhibited by both the K142A and K142E mutants, in conjunction with their altered pi-I-rate profiles, support a role for lysine 142 as a general base involved in the activation of FAAH's serine nucleophile, Moreover, the dramatically different amide versus ester selectivities observed for the K142A and K142E mutants reveal that FAAH's catalytic efficiency and catalytic selectivity depend on distinguishable properties of the same residue, with the former relying on a strong catalytic base and the latter requiring coupled general acid-base catalysis. We hypothesize that FAAH's unusual catalytic properties may empower the enzyme to function effectively as both an amidase and esterase in vivo.
引用
收藏
页码:14125 / 14130
页数:6
相关论文
共 50 条
  • [1] Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo
    Lichtman, AH
    Hawkins, EG
    Griffin, G
    Cravatt, BF
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (01): : 73 - 79
  • [2] Pain and beyond: fatty acid amides and fatty acid amide hydrolase inhibitors in cardiovascular and metabolic diseases
    Pillarisetti, Sivaram
    Alexander, Christopher W.
    Khanna, Ish
    DRUG DISCOVERY TODAY, 2009, 14 (23-24) : 1098 - 1111
  • [3] Synthesis and Evaluation of Paracetamol Esters As Novel Fatty Acid Amide Hydrolase Inhibitors
    Onnis, Valentina
    Congiu, Cenzo
    Bjoerklund, Emmelie
    Hempel, Franziska
    Soederstroem, Emma
    Fowler, Christopher J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (05) : 2286 - 2298
  • [4] Phosphonylation and Activity Loss Mechanism of the Catalytic Triad of Fatty Acid Amide Hydrolase: Theoretical Study of a Model System
    Li Qiang-Gen
    Xue Ying
    Guo Yong
    Yan Guo-Sen
    ACTA PHYSICO-CHIMICA SINICA, 2010, 26 (07) : 1965 - 1975
  • [5] Application of a SCC-DFTB QM/MM approach to the investigation of the catalytic mechanism of fatty acid amide hydrolase
    Capoferri, Luigi
    Mor, Marco
    Sirirak, Jitnapa
    Chudyk, Ewa
    Mulholland, Adrian J.
    Lodola, Alessio
    JOURNAL OF MOLECULAR MODELING, 2011, 17 (09) : 2375 - 2383
  • [6] Application of a SCC-DFTB QM/MM approach to the investigation of the catalytic mechanism of fatty acid amide hydrolase
    Luigi Capoferri
    Marco Mor
    Jitnapa Sirirak
    Ewa Chudyk
    Adrian J. Mulholland
    Alessio Lodola
    Journal of Molecular Modeling , 2011, 17 : 2375 - 2383
  • [7] Luciferin Amides Enable in Vivo Bioluminescence Detection of Endogenous Fatty Acid Amide Hydrolase Activity
    Mofford, David M.
    Adams, Spencer T., Jr.
    Reddy, G. S. Kiran Kumar
    Reddy, Gadarla Randheer
    Miller, Stephen C.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (27) : 8684 - 8687
  • [8] Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications
    Bisogno, T
    De Petrocellis, L
    Di Marzo, V
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (07) : 533 - 547
  • [9] Inactivation Mechanism of the Fatty Acid Amide Hydrolase Inhibitor BIA 10-2474
    Cerqueira, Nuno M. F. S. A.
    Neves, Marco
    Rocha, Juliana
    Soares-da Silva, Patricio
    Palma, P. Nuno
    CHEMBIOCHEM, 2022, 23 (20)
  • [10] Structural analysis of a plant fatty acid amide hydrolase provides insights into the evolutionary diversity of bioactive acylethanolamides
    Aziz, Mina
    Wang, Xiaoqiang
    Tripathi, Ashutosh
    Bankaitis, Vytas A.
    Chapman, Kent D.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (18) : 7419 - 7432